Jack M Cuzick (Jack Cuzick)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 28

Top Topics

Estrogen Receptor

Breast Cancer Risk

Top Venues

British journal of cancer

International journal of cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Dafydd Gareth Evans, Lorna McWilliams, Susan Astley, Adam R Brentnall, Jack M Cuzick, Richard Dobrashian, Stephen W Duffy, Louise S Donnelly, Elaine F Harkness, Fiona Harrison, Michelle N Harvie, Andrew Jerrison, Matthew Machin, Anthony J Maxwell, Sacha J Howell, Stuart J Wright, Katherine Payne, Nadeem Qureshi, Helen Ruane, Jake Southworth, Lynne Fox, Sarah Bowers, Gillian Hutchinson, Emma Thorpe, Fiona M Ulph, Victoria Woof, Anthony Howell, David P French
Correction To: Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420). British journal of cancer (2023)
Dafydd Gareth Evans, Lorna McWilliams, Susan Astley, Adam R Brentnall, Jack M Cuzick, Richard Dobrashian, Stephen W Duffy, Louise S Donnelly, Elaine F Harkness, Fiona Harrison, Michelle N Harvie, Andrew Jerrison, Matthew Machin, Anthony J Maxwell, Sacha J Howell, Stuart J Wright, Katherine Payne, Nadeem Qureshi, Helen Ruane, Jake Southworth, Lynne Fox, Sarah Bowers, Gillian Hutchinson, Emma Thorpe, Fiona M Ulph, Victoria Woof, Anthony Howell, David P French
Correction To: Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420). British journal of cancer (2023)
Dafydd Gareth Evans, Lorna McWilliams, Susan Astley, Adam R Brentnall, Jack M Cuzick, Richard Dobrashian, Stephen W Duffy, Louise S Donnelly, Elaine F Harkness, Fiona Harrison, Michelle N Harvie, Andrew Jerrison, Matthew Machin, Anthony J Maxwell, Sacha J Howell, Stuart J Wright, Katherine Payne, Nadeem Qureshi, Helen Ruane, Jake Southworth, Lynne Fox, Sarah Bowers, Gillian Hutchinson, Emma Thorpe, Fiona M Ulph, Victoria Woof, Anthony Howell, David P French
Correction To: Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420). British journal of cancer (2023)
Jack M Cuzick, Rachael Adcock, Walter Kinney, Philip E Castle, Michael Robertson, Ruth M McDonald, Mark H Stoler, Ruofei Du, Cosette M Wheeler, null null
Impact of HPV testing in Opportunistic Cervical Screening: Support for Primary HPV Screening in the United States. International journal of cancer (2023)
Dafydd Gareth Evans, Lorna McWilliams, Susan Astley, Adam R Brentnall, Jack M Cuzick, Richard Dobrashian, Stephen W Duffy, Louise S Donnelly, Elaine F Harkness, Fiona Harrison, Michelle N Harvie, Andrew Jerrison, Matthew Machin, Anthony J Maxwell, Sacha J Howell, Stuart J Wright, Katherine Payne, Nadeem Qureshi, Helen Ruane, Jake Southworth, Lynne Fox, Sarah Bowers, Gillian Hutchinson, Emma Thorpe, Fiona M Ulph, Victoria Woof, Anthony Howell, David P French
Correction To: Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420). British journal of cancer (2023)
Dafydd Gareth Evans, Lorna McWilliams, Susan Astley, Adam R Brentnall, Jack M Cuzick, Richard Dobrashian, Stephen W Duffy, Louise S Donnelly, Elaine F Harkness, Fiona Harrison, Michelle N Harvie, Andrew Jerrison, Matthew Machin, Anthony J Maxwell, Sacha J Howell, Stuart J Wright, Katherine Payne, Nadeem Qureshi, Helen Ruane, Jake Southworth, Lynne Fox, Sarah Bowers, Gillian Hutchinson, Emma Thorpe, Fiona M Ulph, Victoria Woof, Anthony Howell, David P French
Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420). British journal of cancer (2023)
Jack M Cuzick, Peter D Sasieni
Interpreting the results of noninferiority trials-a review. British journal of cancer 127 (10) (2022)
Rachael Adcock, Belinda Nedjai, Attila T Lorincz, Dorota Scibior-Bentkowska, Rawinder Banwait, Norah Torrez-Martinez, Michael Robertson, Jack M Cuzick, Cosette M Wheeler, null null
DNA methylation testing with S5 for triage of high-risk HPV positive women. International journal of cancer 151 (7) (2022)
Jack M Cuzick
The importance of long-term follow up of participants in clinical trials. British journal of cancer (2022)
Oleg Blyuss, Amanda Dibden, Nathalie J Massat, Dharmishta Parmar, Jack M Cuzick, Stephen W Duffy, Peter Sasieni
A case-control study to evaluate the impact of the breast screening programme on breast cancer incidence in England. Cancer medicine (2022)
Jack M Cuzick, Steven Stone, Lauren Lenz, Darl D Flake, Saradha Rajamani, Henrik Moller, Daniel Maurice Berney, Todd Cohen, Peter T Scardino
Validation of the cell cycle progression score to differentiate indolent from aggressive prostate cancer in men diagnosed through transurethral resection of the prostate biopsy. Cancer reports (Hoboken, N.J.) (2021)
Jonathan Paul Bestwick, Stephen D Auger, Anette-Eleonore Schrag, Donald G Grosset, Sofia Kanavou, Gavin Giovannoni, Andrew John Lees, Jack M Cuzick, Alastair J Noyce
Optimising classification of Parkinson's disease based on motor, olfactory, neuropsychiatric and sleep features. NPJ Parkinson's disease 7 (1) (2021)
Louise Cadman, Caroline Reuter, Mark Jitlal, Michelle Kleeman, Janet Austin, Tony Hollingworth, Anna L Parberry, Lesley Ashdown-Barr, Deepali Patel, Belinda Nedjai, Attila T Lorincz, Jack M Cuzick
A Randomized Comparison of Different Vaginal Self-sampling Devices and Urine for Human Papillomavirus Testing-Predictors 5.1. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 30 (4) (2021)
Cristiana Banila, Attila T Lorincz, Dorota Scibior-Bentkowska, Gary M Clifford, Birhanu Kumbi, Dereje Beyene, Cosette M Wheeler, Kate Cuschieri, Jack M Cuzick, Belinda Nedjai
Clinical performance of methylation as a biomarker for cervical carcinoma in situ and cancer diagnosis: A worldwide study. International journal of cancer 150 (2) (2021)
Caroline Reuter, Matthew Preece, Rawinder Banwait, Sabrina Boer, Jack M Cuzick, Attila Lorincz, Belinda Nedjai
Consistency of the S5 DNA methylation classifier in formalin-fixed biopsies versus corresponding exfoliated cells for the detection of pre-cancerous cervical lesions. Cancer medicine 10 (8) (2021)
Mangesh A Thorat, Pauline M Levey, J Louise Jones, Sarah E Pinder, Nigel J Bundred, Ian S Fentiman, Jack M Cuzick
Prognostic Value of ER and PgR Expression and the Impact of Multi-clonal Expression for Recurrence in Ductal Carcinoma in situ: Results from the UK/ANZ DCIS Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (10) (2021)
Dafydd Gareth Evans, Elke M van Veen, Helen Byers, Eleanor Roberts, Anthony Howell, Sacha J Howell, Elaine F Harkness, Adam R Brentnall, Jack M Cuzick, William G Newman
The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin? International journal of cancer 150 (1) (2021)
Mangesh A Thorat, Pauline M Levey, J Louise Jones, Sarah E Pinder, Nigel J Bundred, Ian S Fentiman, Jack M Cuzick
Prognostic and Predictive Value of HER2 Expression in Ductal Carcinoma In Situ: Results from the UK/ANZ DCIS Randomized Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Richard Buus, Ivana Sestak, Ralf Kronenwett, Sean Ferree, Catherine A Schnabel, Frederick L Baehner, Elizabeth A Mallon, Jack M Cuzick, Mitchell Dowsett
Molecular Drivers of Oncotype DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (2) (2020)
Philip E Castle, Amanda J Pierz, Rachael Adcock, Shagufta Aslam, Partha S Basu, Jerome L Belinson, Jack M Cuzick, Mariam El-Zein, Catterina Ferreccio, Cynthia Firnhaber, Eduardo L Franco, Patti E Gravitt, Sandra D Isidean, John Lin, Salaheddin M Mahmud, Joseph Monsonego, Richard Muwonge, Samuel Ratnam, Mahboobeh Safaeian, Mark Schiffman, Jennifer S Smith, Avril Swarts, Thomas C Wright, Vanessa Van De Wyngard, Long Fu Xi
A Pooled Analysis to Compare the Clinical Characteristics of Human Papillomavirus-positive and -Negative Cervical Precancers. Cancer prevention research (Philadelphia, Pa.) 13 (10) (2020)
Ivana Sestak, Martin Filipits, Richard Buus, Margaretha Rudas, Marija Balić, Michael Knauer, Ralf Kronenwett, Florian Fitzal, Jack M Cuzick, Michael Gnant, Richard Greil, Mitch Dowsett, Peter Dubsky
Prognostic Value of EndoPredict in Women with Hormone Receptor-Positive, HER2-Negative Invasive Lobular Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (17) (2020)
Leticia Torres-Ibarra, Attila T Lorincz, Cosette M Wheeler, Jack M Cuzick, Rubí Hernández-López, Donna Spiegelman, Leith León-Maldonado, Berenice Rivera-Paredez, Pablo Méndez-Hernández, Eduardo Cesar Lazcano-Ponce, Jorge Salmerón
Adjunctive testing by cytology, p16/Ki-67 dual-stained cytology or HPV16/18 E6 oncoprotein for the management of HPV16/18 screen-positive women. International journal of cancer 148 (9) (2020)
Kara L Britt, Jack M Cuzick, Kelly-Anne Phillips
Key steps for effective breast cancer prevention. Nature reviews. Cancer 20 (8) (2020)
Arianis Tatiana Ramírez, Gloria Inés Sánchez, Belinda Nedjai, María Cecilia Agudelo, Adam R Brentnall, Kate Cuschieri, Kelly Melisa Castañeda, Jack M Cuzick, Attila T Lorincz, null null
Effective methylation triage of HPV positive women with abnormal cytology in a middle-income country. International journal of cancer 148 (6) (2020)
Evenda Dench, Daniela Bond-Smith, Ellie Darcey, Grant Lee, Ye K Aung, Ariane Chan, Jack M Cuzick, Ze Y Ding, Chris F Evans, Jennifer Harvey, Ralph Highnam, Meng-Kang Hsieh, Despina Kontos, Shuai Li, Shivaani Mariapun, Carolyn Nickson, Tuong Linh Nguyen, Said Pertuz, Pietro Procopio, Nadia Rajaram, Kathy Repich, Maxine Tan, Soo-Hwang Teo, Nhut Ho Trinh, Giske Ursin, Chao Wang, Isabel Dos-Santos-Silva, Valerie McCormack, Mads Nielsen, John Shepherd, John L Hopper, Jennifer Stone
Measurement challenge: protocol for international case-control comparison of mammographic measures that predict breast cancer risk. BMJ open 9 (12) (2019)
Richard Buus, Ivana Sestak, Stephen Barron, Tony Loughman, Bozena Fender, Cesar Lopez Ruiz, Peter Dynoodt, Chan-Ju Angel Wang, Des O'Leary, William M Gallagher, Mitch Dowsett, Jack M Cuzick
Validation of the OncoMasTR Risk Score in Estrogen Receptor-Positive/HER2-Negative Patients: A TransATAC study. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (3) (2019)
Rachael Adcock, Jack M Cuzick, William C Hunt, Ruth M McDonald, Cosette M Wheeler, null null
Role of HPV Genotype, Multiple Infections, and Viral Load on the Risk of High-Grade Cervical Neoplasia. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 28 (11) (2019)
Louisa L Lo, Ian M Collins, Mathias Bressel, Phyllis N Butow, Jon David Emery, Louise Anne Keogh, Prue C Weideman, Emma Steel, John L Hopper, Alison H Trainer, Gregory B Mann, Adrian Bickerstaffe, Antonis C Antoniou, Jack M Cuzick, Kelly-Anne Phillips
The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing. JMIR formative research 2 (2) (2018)